The value of miR-199a-3p and/or RB1 expression as a biomarker for RA progression warrants further study, and developing strategies to target miR-199a-3p may represent a novel approach to improve the clinical outcome of RA. The gene discussed is RB1; the disease is rheumatoid arthritis.